FGF-23 correlates with endocrine and metabolism dysregulation, worse cardiac and renal function, inflammation level, stenosis degree, and independently predicts in-stent restenosis risk in coronary heart disease patients underwent drug-eluting-stent PCI
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
FGF-23 correlates with endocrine and metabolism dysregulation, worse cardiac and renal function, inflammation level, stenosis degree, and independently predicts in-stent restenosis risk in coronary heart disease patients underwent drug-eluting-stent PCI
Authors
Keywords
-
Journal
BMC Cardiovascular Disorders
Volume 21, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-01-08
DOI
10.1186/s12872-020-01839-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Fibroblast growth factor 23: a biomarker of fibrosis and prognosis in heart failure with preserved ejection fraction
- (2020) Clotilde Roy et al. ESC Heart Failure
- A review on coronary artery disease, its risk factors, and therapeutics
- (2019) Arup Kr. Malakar et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE Study
- (2019) Ferdinando Carlo Sasso et al. Cardiovascular Diabetology
- MicroRNA‐33 and SIRT1 influence the coronary thrombus burden in hyperglycemic STEMI patients
- (2019) Nunzia D'Onofrio et al. JOURNAL OF CELLULAR PHYSIOLOGY
- The relationship between serum FGF-23 concentration and insulin resistance, prediabetes and dyslipidemia in obese children and adolescents
- (2019) Yesim Kutluturk et al. JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM
- PTH, vitamin D, and the FGF-23-klotho axis and heart: Going beyond the confines of nephrology
- (2018) José Alberto Navarro-García et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Effects of incretin treatment on cardiovascular outcomes in diabetic STEMI-patients with culprit obstructive and multivessel non obstructive-coronary-stenosis
- (2018) Raffaele Marfella et al. Diabetology & Metabolic Syndrome
- Paracrine Effects of FGF23 on the Heart
- (2018) Maren Leifheit-Nestler et al. Frontiers in Endocrinology
- Comprehensive analysis of predictive factors for rapid angiographic stenotic progression and restenosis risk in coronary artery disease patients underwent percutaneous coronary intervention with drug-eluting stents implantation
- (2018) Yanqiang Wu et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- Is FGF-23 an early indicator of atherosclerosis and cardiac dysfunction in patients with gestational diabetes?
- (2018) Dilek Tuzun et al. Archives of Endocrinology Metabolism
- Prevalence of Pre-Diabetes across Ethnicities: A Review of Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT) for Classification of Dysglycaemia
- (2017) Wilson Yip et al. Nutrients
- Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting in Patients With Left Main Coronary Artery Stenosis
- (2017) Daniele Giacoppo et al. JAMA Cardiology
- Effects of exercise-based cardiac rehabilitation in patients after percutaneous coronary intervention: A meta-analysis of randomized controlled trials
- (2017) Xinyu Yang et al. Scientific Reports
- What is the optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug-eluting stent implantation?
- (2016) J. E. Basaraba et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- FGF-23 and cardiovascular disease
- (2016) Jasveen Batra et al. Current Opinion in Endocrinology Diabetes and Obesity
- Plasma FGF23 and Calcified Atherosclerotic Plaque in African Americans with Type 2 Diabetes Mellitus
- (2015) Barry I. Freedman et al. AMERICAN JOURNAL OF NEPHROLOGY
- Influence of insulin resistance on in-stent restenosis in patients undergoing coronary drug-eluting stent implantation after long-term angiographic follow-up
- (2015) Liang-Ping Zhao et al. CORONARY ARTERY DISEASE
- Sirtuin 6 Expression and Inflammatory Activity in Diabetic Atherosclerotic Plaques: Effects of Incretin Treatment
- (2014) Maria Luisa Balestrieri et al. DIABETES
- Fibroblast Growth Factor-23, Cardiovascular Prognosis, and Benefit of Angiotensin-Converting Enzyme Inhibition in Stable Ischemic Heart Disease
- (2014) Jacob A. Udell et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Carbonic Anhydrase Activation Is Associated With Worsened Pathological Remodeling in Human Ischemic Diabetic Cardiomyopathy
- (2014) Daniele Torella et al. Journal of the American Heart Association
- Uric acid and chronic kidney disease: which is chasing which?
- (2013) R. J. Johnson et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Peri-Procedural Tight Glycemic Control during Early Percutaneous Coronary Intervention Is Associated with a Lower Rate of In-Stent Restenosis in Patients with Acute ST-Elevation Myocardial Infarction
- (2012) Raffaele Marfella et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Innate Immune Activity in Plaque of Patients with Untreated andl-Thyroxine-Treated Subclinical Hypothyroidism
- (2011) Raffaele Marfella et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- FGF23 induces left ventricular hypertrophy
- (2011) Christian Faul et al. JOURNAL OF CLINICAL INVESTIGATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More